Ran Nussbaum

Ran Nussbaum has served as Chairman of the board of directors since April 2016. Mr. Nussbaum has served as a Managing Partner and the Co-Founder of The Pontifax Group since January 2004. He also serves as a board member on many of Pontifax’s portfolio companies, including Kite Pharma (acquired by Gilead), ArQule (acquired by Merck & Co.), Ccam Ltd (acquired by Merck & Co.), Prevail Therapeutics (acquired by Eli Lilly), UroGen Pharma and Eloxx Pharmaceuticals.